ID21850A - Formula senyawa baru - Google Patents

Formula senyawa baru

Info

Publication number: ID21850A
Authority: ID; Indonesia
Prior art keywords: new compound; compound formula; formula; new; compound
Prior art date: 1996-12-20

Application number

IDW990483A

Other languages

English (en)

Inventor

Martin Bohlin

Karol Horvath

Sverker Von Unge

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-20

Filing date

1997-12-16

Publication date

1999-08-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20405146&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID21850(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-12-16 Application filed by Astra Ab filed Critical Astra Ab

1999-08-05 Publication of ID21850A publication Critical patent/ID21850A/id

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IDW990483A 1996-12-20 1997-12-16 Formula senyawa baru ID21850A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9604793A SE510666C2 (sv)	1996-12-20	1996-12-20	Nya Kristallmodifikationer

Publications (1)

Publication Number	Publication Date
ID21850A true ID21850A (id)	1999-08-05

Family

ID=20405146

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW990483A ID21850A (id)	1996-12-20	1997-12-16	Formula senyawa baru

Country Status (37)

Country	Link
US (1)	US6162816A (id)
EP (1)	EP0946547B1 (id)
JP (1)	JP4402174B2 (id)
KR (1)	KR20000069595A (id)
CN (1)	CN1109684C (id)
AR (1)	AR010361A1 (id)
AT (1)	ATE236898T1 (id)
AU (1)	AU730129B2 (id)
BR (1)	BR9714059A (id)
CA (1)	CA2274076C (id)
CZ (1)	CZ294784B6 (id)
DE (1)	DE69720774T2 (id)
DK (1)	DK0946547T3 (id)
EE (1)	EE03923B1 (id)
EG (1)	EG24414A (id)
ES (1)	ES2194231T3 (id)
HK (1)	HK1022909A1 (id)
HU (1)	HU227589B1 (id)
ID (1)	ID21850A (id)
IL (1)	IL130450A0 (id)
IS (1)	IS1981B (id)
MY (1)	MY117032A (id)
NO (1)	NO317191B1 (id)
NZ (1)	NZ336024A (id)
PL (1)	PL190377B1 (id)
PT (1)	PT946547E (id)
RS (1)	RS49685B (id)
RU (1)	RU2184734C2 (id)
SA (1)	SA97180739B1 (id)
SE (1)	SE510666C2 (id)
SI (1)	SI0946547T1 (id)
SK (1)	SK285151B6 (id)
TR (1)	TR199901410T2 (id)
TW (1)	TW538039B (id)
UA (1)	UA55436C2 (id)
WO (1)	WO1998028294A1 (id)
ZA (1)	ZA9711046B (id)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6699885B2 (en)	1996-01-04	2004-03-02	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and methods of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6645988B2 (en)	1996-01-04	2003-11-11	Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
SI20019A (sl) *	1998-07-13	2000-02-29	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
IL142703A (en)	1998-11-10	2006-04-10	Astrazeneca Ab	Crystalline form of omeprazole
UA72748C2 (en) *	1998-11-10	2005-04-15	Astrazeneca Ab	A novel crystalline form of omeprazole
JP3926936B2 (ja)	1998-11-16	2007-06-06	エーザイ・アール・アンド・ディー・マネジメント株式会社	スルホキシド誘導体・アセトン錯体およびその製造法
SE9804003D0 (sv) *	1998-11-23	1998-11-23	Astra Ab	A method of producing drug particles
SE9900274D0 (sv) *	1999-01-28	1999-01-28	Astra Ab	New compound
JP2000344739A (ja) *	1999-06-01	2000-12-12	Sumitomo Chem Co Ltd	Ｎ−保護−アゼチジン−２−カルボン酸の製造方法
TWI289557B (en)	1999-06-17	2007-11-11	Takeda Chemical Industries Ltd	A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
SE0000774D0 (sv)	2000-03-08	2000-03-08	Astrazeneca Ab	New formulation
SE0000773D0 (sv) *	2000-03-08	2000-03-08	Astrazeneca Ab	New formulation
US7169799B2 (en) *	2000-05-15	2007-01-30	Takeda Pharmaceutical Company Limited	Process for producing crystal
GB0016040D0 (en) *	2000-06-29	2000-08-23	Glaxo Group Ltd	Novel process for preparing crystalline particles
EP1306375B1 (en)	2000-08-04	2006-10-11	Takeda Pharmaceutical Company Limited	Salts of benzimidazole compound and application thereof
SI20875A (sl) *	2001-04-25	2002-10-31	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Kristalna oblika omeprazola
DE60237087D1 (de)	2001-06-01	2010-09-02	Pozen Inc	Pharmazeutische zusammensetzungen für die koordinierte abgabe von nsaid
US8206741B2 (en)	2001-06-01	2012-06-26	Pozen Inc.	Pharmaceutical compositions for the coordinated delivery of NSAIDs
GB2376231A (en)	2001-06-06	2002-12-11	Cipla Ltd	Benzimidazole-cyclodextrin inclusion complex
SE0102993D0 (sv)	2001-09-07	2001-09-07	Astrazeneca Ab	New self emulsifying drug delivery system
ATE353887T1 (de) *	2002-06-27	2007-03-15	Reddys Lab Ltd Dr	Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salze
US7169793B2 (en)	2002-06-27	2007-01-30	Dr. Reddy's Laboratories Limited	Process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
CA2501424A1 (en) *	2002-08-30	2004-03-11	Dr. Reddy's Laboratories Limited	Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
EP1552833B1 (en)	2002-10-16	2016-12-28	Takeda Pharmaceutical Company Limited	Process for producing an amorphous optically active isomer of lansoprazole
CN1728997A (zh) *	2002-10-22	2006-02-01	兰贝克赛实验室有限公司	(es)奥美拉唑的无定形盐
WO2004046134A2 (en) *	2002-11-18	2004-06-03	Dr. Reddy's Laboratories Limited	Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation
BRPI0407906A (pt) *	2003-02-28	2006-02-14	Ranbaxy Lab Ltd	polimorfos de s-omeprazol
KR100714375B1 (ko) *	2003-03-24	2007-05-02	에자이 알앤드디 매니지먼트 가부시키가이샤	술폭시드 유도체 또는 그 염의 아몰퍼스의 제조방법
EP1633736A1 (en) *	2003-05-05	2006-03-15	Ranbaxy Laboratories Limited	Barium salt of benzimidazole derivative
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
SE0400410D0 (sv) *	2004-02-20	2004-02-20	Astrazeneca Ab	New compounds
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en)	2004-05-25	2014-08-26	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP5563735B2 (ja)	2004-06-16	2014-07-30	タケダファーマシューティカルズユー．エス．エー．インコーポレイティド	Ｐｐｉ多回剤形
WO2006001753A1 (en)	2004-06-24	2006-01-05	Astrazeneca Ab	New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
ES2246149B1 (es) *	2004-07-02	2007-06-01	Esteve Quimica, S.A.	Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
RU2007145207A (ru) *	2005-05-06	2009-06-20	Гленмарк Фармасьютикалз Лимитед (In)	Стронциваемая соль эзомепразола, способ ее получения и содержащее ее фармацевтические композиции
JP2008545768A (ja) *	2005-06-08	2008-12-18	レツク・フアーマシユーテイカルズ・デー・デー	オメプラゾールナトリウムの結晶性溶媒和物
WO2006134605A1 (en)	2005-06-15	2006-12-21	Hetero Drugs Limited	Amorphous esomeprazole hydrate
NL2000126C2 (nl) *	2005-07-15	2008-01-29	Solvay	Werkwijze voor de vervaardiging van eptifibatide.
US20070043085A1 (en) *	2005-08-19	2007-02-22	Glenmark Pharmaceuticals Limited	Process for the preparation of amorphous form of neutral esomeprazole
US7576219B2 (en)	2005-10-26	2009-08-18	Hanmi Pharm. Co., Ltd	Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
US20090082572A1 (en) *	2005-11-14	2009-03-26	Hetero Drugs Limited	Process for amorphous esomeprazole
US8124779B2 (en) *	2005-12-05	2012-02-28	Astrazeneca Ab	Process for the preparation of esomeprazole non-salt form
EP1801110A1 (en)	2005-12-22	2007-06-27	KRKA, tovarna zdravil, d.d., Novo mesto	Esomeprazole arginine salt
US7799925B2 (en)	2005-12-28	2010-09-21	Unión Químico Farmacéutica, S.A.	Process for the preparation of the (S)-enantiomer of omeprazole
EP2000468A1 (en) *	2007-05-09	2008-12-10	Dr. Reddy's Laboratories Ltd.	Esomeprazole salts and processes for preparation thereof
US8106210B2 (en)	2007-10-08	2012-01-31	Hetero Drugs Limited	Polymorphs of esomeprazole salts
CL2009000547A1 (es)	2008-03-10	2010-05-07	Takeda Pharmaceuticals Co	Forma cristalina de (r)-2[[[3-metil-4-(2,2,2-trifluoroetoxi)-2-piridinil]metil]sulfinil]-1h-bencimidazol, metodo de preparacion; composicion farmaceutica y su uso para la profilaxis o tratamiento de ulcera peptica, gastritis, esofagitis erosiva, esofago de barret,dispepsia funcional, cancer gastrico.
EP2143722A1 (en)	2008-07-09	2010-01-13	Lek Pharmaceuticals D.D.	Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
EA201100313A1 (ru)	2008-09-09	2011-10-31	Астразенека Аб	Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
SG176724A1 (en)	2009-06-25	2012-01-30	Astrazeneca Ab	Method for treating a patient at risk for developing an nsaid-associated ulcer
WO2011071982A2 (en)	2009-12-08	2011-06-16	Codexis, Inc.	Synthesis of prazole compounds
DK2649187T3 (da)	2010-12-08	2018-01-29	Codexis Inc	Biokatalysatorer og fremgangsmåder til syntesen af armodafinil
WO2013101897A2 (en)	2011-12-28	2013-07-04	Pozen Inc.	Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
RU2501549C1 (ru)	2012-08-30	2013-12-20	Авва Девелопмент Лтд	Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни
CN107043367A (zh) *	2017-05-26	2017-08-15	重庆莱美隆宇药业有限公司	一种中性s‑奥美拉唑的干燥工艺
WO2024075017A1 (en)	2022-10-04	2024-04-11	Zabirnyk Arsenii	Inhibition of aortic valve calcification

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE7804231L (sv) *	1978-04-14	1979-10-15	Haessle Ab	Magsyrasekretionsmedel
SE8301182D0 (sv) *	1983-03-04	1983-03-04	Haessle Ab	Novel compounds
GB2189698A (en) *	1986-04-30	1987-11-04	Haessle Ab	Coated omeprazole tablets
DE4035455A1 (de) *	1990-11-08	1992-05-14	Byk Gulden Lomberg Chem Fab	Enantiomerentrennung
SE9301830D0 (sv) *	1993-05-28	1993-05-28	Ab Astra	New compounds
US5877192A (en) *	1993-05-28	1999-03-02	Astra Aktiebolag	Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
SE9302396D0 (sv) *	1993-07-09	1993-07-09	Ab Astra	A novel compound form
DE69522921T2 (de) *	1994-07-08	2002-04-11	Astrazeneca Ab	Aus mehreren einzeleinheiten zusammengesetzte dosierungsform in tablettenform (i)

1996
- 1996-12-20 SE SE9604793A patent/SE510666C2/sv unknown
1997
- 1997-12-08 TW TW086118449A patent/TW538039B/zh not_active IP Right Cessation
- 1997-12-09 ZA ZA9711046A patent/ZA9711046B/xx unknown
- 1997-12-16 EE EEP199900259A patent/EE03923B1/xx not_active IP Right Cessation
- 1997-12-16 PL PL97334297A patent/PL190377B1/pl not_active IP Right Cessation
- 1997-12-16 WO PCT/SE1997/002125 patent/WO1998028294A1/en not_active Application Discontinuation
- 1997-12-16 ID IDW990483A patent/ID21850A/id unknown
- 1997-12-16 ES ES97951367T patent/ES2194231T3/es not_active Expired - Lifetime
- 1997-12-16 PT PT97951367T patent/PT946547E/pt unknown
- 1997-12-16 HU HU0001547A patent/HU227589B1/hu not_active IP Right Cessation
- 1997-12-16 DE DE69720774T patent/DE69720774T2/de not_active Expired - Lifetime
- 1997-12-16 CA CA002274076A patent/CA2274076C/en not_active Expired - Fee Related
- 1997-12-16 CZ CZ19992202A patent/CZ294784B6/cs not_active IP Right Cessation
- 1997-12-16 NZ NZ336024A patent/NZ336024A/en not_active IP Right Cessation
- 1997-12-16 BR BR9714059-7A patent/BR9714059A/pt not_active Application Discontinuation
- 1997-12-16 AR ARP970105920A patent/AR010361A1/es active IP Right Grant
- 1997-12-16 JP JP52868598A patent/JP4402174B2/ja not_active Expired - Fee Related
- 1997-12-16 CN CN97180849A patent/CN1109684C/zh not_active Expired - Fee Related
- 1997-12-16 RU RU99116303/04A patent/RU2184734C2/ru not_active IP Right Cessation
- 1997-12-16 SK SK765-99A patent/SK285151B6/sk not_active IP Right Cessation
- 1997-12-16 RS YUP-281/99A patent/RS49685B/sr unknown
- 1997-12-16 EP EP97951367A patent/EP0946547B1/en not_active Expired - Lifetime
- 1997-12-16 TR TR1999/01410T patent/TR199901410T2/xx unknown
- 1997-12-16 IL IL13045097A patent/IL130450A0/xx not_active IP Right Cessation
- 1997-12-16 SI SI9730528T patent/SI0946547T1/xx unknown
- 1997-12-16 KR KR1019997005574A patent/KR20000069595A/ko active Search and Examination
- 1997-12-16 DK DK97951367T patent/DK0946547T3/da active
- 1997-12-16 AT AT97951367T patent/ATE236898T1/de active
- 1997-12-16 US US09/000,154 patent/US6162816A/en not_active Expired - Lifetime
- 1997-12-16 UA UA99073869A patent/UA55436C2/uk unknown
- 1997-12-16 AU AU55026/98A patent/AU730129B2/en not_active Ceased
- 1997-12-19 MY MYPI97006176A patent/MY117032A/en unknown
- 1997-12-20 EG EG136097A patent/EG24414A/xx active
- 1997-12-27 SA SA97180739A patent/SA97180739B1/ar unknown
1999
- 1999-06-07 IS IS5070A patent/IS1981B/is unknown
- 1999-06-21 NO NO19993068A patent/NO317191B1/no not_active IP Right Cessation
2000
- 2000-03-31 HK HK00101986A patent/HK1022909A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
AR010361A1 (es)	2000-06-07
NO317191B1 (no)	2004-09-13
CN1109684C (zh)	2003-05-28
TR199901410T2 (xx)	1999-08-23
SK76599A3 (en)	1999-12-10
SK285151B6 (sk)	2006-07-07
KR20000069595A (ko)	2000-11-25
DK0946547T3 (da)	2003-06-30
PL190377B1 (pl)	2005-12-30
IS5070A (is)	1999-06-07
CZ220299A3 (cs)	2000-02-16
UA55436C2 (uk)	2003-04-15
SI0946547T1 (en)	2003-10-31
EP0946547B1 (en)	2003-04-09
AU730129B2 (en)	2001-02-22
HU0001547D0 (id)	2002-05-29
AU5502698A (en)	1998-07-17
WO1998028294A1 (en)	1998-07-02
HUP0001547A2 (hu)	2002-05-29
NO993068D0 (no)	1999-06-21
NO993068L (no)	1999-06-21
PT946547E (pt)	2003-07-31
US6162816A (en)	2000-12-19
MY117032A (en)	2004-04-30
HU227589B1 (en)	2011-09-28
DE69720774T2 (de)	2004-02-05
CA2274076A1 (en)	1998-07-02
CN1241183A (zh)	2000-01-12
SA97180739B1 (ar)	2006-05-20
RU2184734C2 (ru)	2002-07-10
PL334297A1 (en)	2000-02-14
ATE236898T1 (de)	2003-04-15
HUP0001547A3 (en)	2002-06-28
SE9604793L (sv)	1998-06-21
ES2194231T3 (es)	2003-11-16
ZA9711046B (en)	1998-06-22
IL130450A0 (en)	2000-06-01
TW538039B (en)	2003-06-21
EE9900259A (et)	2000-02-15
SE510666C2 (sv)	1999-06-14
NZ336024A (en)	2001-02-23
EE03923B1 (et)	2002-12-16
EG24414A (en)	2009-05-25
RS49685B (sr)	2007-11-15
IS1981B (is)	2005-01-14
CZ294784B6 (cs)	2005-03-16
BR9714059A (pt)	2000-05-09
CA2274076C (en)	2008-09-30
HK1022909A1 (en)	2000-08-25
DE69720774D1 (de)	2003-05-15
SE9604793D0 (sv)	1996-12-20
EP0946547A1 (en)	1999-10-06
JP4402174B2 (ja)	2010-01-20
YU28199A (sh)	2002-03-18
JP2001507025A (ja)	2001-05-29

Publication	Publication Date	Title
ID21850A (id)	1999-08-05	Formula senyawa baru
ID19430A (id)	1998-07-09	Senyawa senyawa heterosiklik
BR9709230A (pt)	1999-08-10	Composto
ID19609A (id)	1998-07-23	Senyawa-senyawa heterosiklik
ID19403A (id)	1998-07-09	Senyawa-senyawa heterosiklik
ID16152A (id)	1997-09-04	Senyawa-senyawa triaril
ID21881A (id)	1999-08-05	Turunan-turunan baru pirazol tersubstitusi
BR9509760A (pt)	1998-06-30	Composto
ID15904A (id)	1997-08-14	Senyawa-senyawa tiofenopirimidina
BR9707051A (pt)	1999-07-20	Composto
BR9710352A (pt)	1999-08-17	Compostos piridilpirrole
DE69716924D1 (de)	2002-12-12	Phosphonat-nukleotid-verbindungen
ID18685A (id)	1998-04-30	Senyawa trisiklik tersubstitusi
ID18431A (id)	1998-04-09	Senyawa-senyawa baru
ID16660A (id)	1997-10-30	Senyawa-senyawa b-laktam monosiklik baru
BR9705635A (pt)	1999-05-18	Compostos
BR9711205A (pt)	1999-08-17	Composto
DK0923594T3 (da)	2003-02-10	Bromotiacumicinforbindelser
ID19433A (id)	1998-07-09	Senyaw-senyawa baru
DE69709659D1 (de)	2002-02-21	Halopropargyl-einschlussverbindungen
ID16684A (id)	1997-10-30	Senyawa-senyawa sulfonilurea baru
ID18889A (id)	1998-05-20	Senyawa baru
ID22144A (id)	1999-09-09	Senyawa-senyawa baru
BR9509740A (pt)	1997-10-21	Compostos 18-nor-vitamina d
ID16373A (id)	1997-09-25	Senyawa-senyawa baru